{
    "nctId": "NCT02638935",
    "briefTitle": "Evaluation of Virtual Touch Tissue Imaging Quantification (VTIQ - 2D-SWE) in the Assessment of BI-RADS\u00ae 3 and 4 Lesions",
    "officialTitle": "Evaluation of Virtual Touch Tissue Imaging Quantification (VTIQ - 2D-SWE) in the Assessment of BI-RADS\u00ae 3 and 4 Lesions: Can Patient Selection for Biopsy be Improved? - A Confirmatory Multi-Center-Study",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Neoplasms",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "NON_RANDOMIZED",
    "primaryPurpose": "DIAGNOSTIC",
    "enrollmentCount": 1304,
    "primaryOutcomeMeasure": "Standard chi-square test at a two-sided significance level of 5% to test the diagnostic accuracy of Virtual Touch Tissue Imaging Quantification (VTIQ) in the differentiation of BI-RADS\u00ae 3 and 4a lesions",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Female\n* Age \u226518 years\n* Patients with a lesion \u2265 0.5 cm in largest diameter size, initially scored BI-RADS\u00ae 3, 4a, 4b or 4c in B-mode ultrasound\n* Informed consent about histological examination (core cut biopsy (CCB), vacuum-assisted biopsy (VAB), fine needle aspiration (FNA) or surgery) has already been given in the course of clinical routine\n* Signed informed consent of study participation\n\nExclusion Criteria:\n\n* Pregnant or lactating women\n* Women with breast implants on the same side as the lesion\n* Women that underwent local radiation or chemotherapy within the last 12 months\n* Women with history of breast cancer or breast surgery in the same quadrant\n* Lesions in or close to scar tissue (\\< 1cm)\n* Skin lesions or lesions that have been biopsied previously\n* Lesion larger than 4 cm in the longest dimension\n* No lesion should be included when more than 50% of the lesion is further down than 4 cm beneath the skin level.",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}